PPD, Inc.

Paul Covington, M.D. is retiring as executive vice president of development and chief medical officer of PPD, Inc., effective June 30. He will serve as a special project adviser through January 2009 to assist with selected projects and the transition of his responsibilities.
   
“Paul is one of the most talented physicians in our industry, and his leadership and unwavering commitment to excellence have played a significant role in the continued growth and success of our company,” said Fred Eshelman, chief executive officer. “I am grateful for Paul’s many contributions and tireless efforts during his 17-year tenure with PPD. On behalf of our board of directors and all of our employees, I wish him well in his retirement and immense satisfaction in his pursuit of personal interests outside of our industry.”
   
Dr. Covington has global responsibility for regulatory affairs, pharmacovigilance, medical communications, laboratory and Phase I services. He joined the company in 1991 as medical director and served as senior vice president of medical and regulatory affairs and chief safety officer prior to being promoted to his current role in 2002.
   
The company anticipates naming a successor to Dr. Covington by mid-2008. The company also expects to enter into a consulting agreement with him following his full retirement in 2009.